Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges

Abstract EN

Liver-function decompensation or hepatocellular carcinoma (HCC) gradually appears after chronic hepatitis B progresses to cirrhosis.

Effective antiviral treatment can significantly improve the long-term prognosis of decompensated patients, and some patients present recompensation of decompensated hepatitis B cirrhosis.

At present, there are limited research data on the recompensation of decompensated hepatitis B cirrhosis.

There is still controversy regarding the evaluation time, evaluation indicators, influencing factors, and long-term prognosis of recompensation.